Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world.

Established in Barcelona, Spain in 1940, we are an industry leader in the production of plasma-derived medicines, with 20,000 employees across
30 countries.

As our business continues to grow, we remain committed to a long-term, sustainable and responsible vision.

Mission

We improve the health and well-being of patients around the world.

Family heritage

We trace our roots back to 1940 when Dr. Josep Antoni Grífols i Roig founded Laboratorios Grifols in Barcelona, Spain.

COMMITMENT

Commitment to patients

The patients we serve around the world are able to lead better lives thanks to plasma-derived medicines and donors. Patients inspire the work we do every day.

Latest news

12 oct, 2018 FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
Read more

08 oct, 2018 Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support
Read more

04 sep, 2018 FDA Approves Grifols New GamaSTAN® (immune globulin [human]) to Treat Patients Exposed to Hepatitis A and Measles
Read more

BIOSCIENCE

Plasma journey

Grifols plasma medicines are a unique class of biologic therapies that require a lengthy and complex manufacturing process.

Company

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.

Commitment

We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.

Innovation

Since the foundation of Grifols, our on-going innovation has helped shape industry standards in the plasma medicines sector.

Team

The efforts of every member of the Grifols team enable us to achieve our mission of improving people's health and well-being.